Terms: = Endocrine gland cancer AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16 AND Treatment
24 results:
1. Blood leukocytes as a non-invasive diagnostic tool for thyroid nodules: a prospective cohort study.
Wang F; Zhao D; Xu WY; Liu Y; Sun H; Lu S; Ji Y; Jiang J; Chen Y; He Q; Gong C; Liu R; Su Z; Dong Y; Yan Z; Liu L
BMC Med; 2024 Apr; 22(1):147. PubMed ID: 38561764
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic Differences Between Surveillance and Active treatment After Initial Orchiectomy in Patients With Stage I Mixed Germ Cell Tumors of the Testis: A Propensity Score Matching Analysis.
Du Y; Liu L; Zou B; Chen Z; Chen Q; Deng R; Yang P
J Surg Res; 2024 Feb; 294():26-36. PubMed ID: 37857140
[TBL] [Abstract] [Full Text] [Related]
3. Marital Status Independently Predicts Mortality in Adult Patients with Craniopharyngioma: A SEER-Based Study.
Pham J; Rhee B; Malpass R; Ozcan EE; Shaaya E; Doberstein C; Toms S; Sullivan P
World Neurosurg; 2023 Jul; 175():e367-e379. PubMed ID: 37003530
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy of gemcitabine in combination with nanoparticle albumin-bound paclitaxel in the treatment of recurrent ovarian cancer: A retrospective single institution review.
Kase AM; Azzouqa AG; Kochuveettil S; Colon-Otero G
Cancer Med; 2023 Apr; 12(8):9434-9438. PubMed ID: 36806695
[TBL] [Abstract] [Full Text] [Related]
5. Related factor analysis for predicting large-volume central cervical lymph node metastasis in papillary thyroid carcinoma.
Tan L; Ji J; Sharen G; Liu Y; Lv K
Front Endocrinol (Lausanne); 2022; 13():935559. PubMed ID: 36046785
[TBL] [Abstract] [Full Text] [Related]
6. Correlation analysis of I-131 SPECT/CT uptake parameters with the success ablation treatment of thyroid remnant in patients with low-intermediate-risk differentiated thyroid cancer.
Zhang Q; Xu W
Nucl Med Commun; 2022 Oct; 43(10):1051-1057. PubMed ID: 35972341
[TBL] [Abstract] [Full Text] [Related]
7. Single-Cell Transcriptome Analysis Reveals Inter-Tumor Heterogeneity in Bilateral Papillary Thyroid Carcinoma.
Wang T; Shi J; Li L; Zhou X; Zhang H; Zhang X; Wang Y; Liu L; Sheng L
Front Immunol; 2022; 13():840811. PubMed ID: 35515000
[TBL] [Abstract] [Full Text] [Related]
8. Metabolic and functional imaging employment in the differentiation of brown tumors from bone metastases in a case of primary papillary thyroid cancer and parathyroid adenoma: case report.
Al-Rasheed U; Barakat F; Al-Ibraheem A
J Egypt Natl Canc Inst; 2021 Oct; 33(1):30. PubMed ID: 34657985
[TBL] [Abstract] [Full Text] [Related]
9. Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study.
Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Yoon SH; Kim YB
PLoS One; 2021; 16(4):e0250723. PubMed ID: 33909674
[TBL] [Abstract] [Full Text] [Related]
10. [Bioinformatics analysis of drug-resistant ceRNA in epithelial ovarian cancer].
Pan ZM; Tan FC; Chen CX; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2021 Feb; 56(2):121-130. PubMed ID: 33631884
[No Abstract] [Full Text] [Related]
11. Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic cancer That Progressed After Gemcitabine (SEQUOIA).
Hecht JR; Lonardi S; Bendell J; Sim HW; Macarulla T; Lopez CD; Van Cutsem E; Muñoz Martin AJ; Park JO; Greil R; Wang H; Hozak RR; Gueorguieva I; Lin Y; Rao S; Ryoo BY
J Clin Oncol; 2021 Apr; 39(10):1108-1118. PubMed ID: 33555926
[TBL] [Abstract] [Full Text] [Related]
12. Assessment of diagnostic utility of multivariate diagnostic models in differential diagnosis of ovarian tumors.
Horała A; Swiatly A; Lorek J; Kokot ZJ; Matysiak J; Nowak-Markwitz E
Ginekol Pol; 2018; 89(10):568-572. PubMed ID: 30393846
[TBL] [Abstract] [Full Text] [Related]
13. Postoperative chemotherapy had no prognostic effect on early-staged young ovarian cancer with unilateral resection.
Zhang X; Wang S; Zhao S; Sun Y; Yang G
Cancer Med; 2018 Nov; 7(11):5488-5496. PubMed ID: 30306725
[TBL] [Abstract] [Full Text] [Related]
14. Predictive Factors for Surgical Morbidities and Adjuvant Chemotherapy Delay for Advanced Ovarian cancer Patients Treated by Primary Debulking Surgery or Interval Debulking Surgery.
Castro BGR; Dos Reis R; Cintra GF; Sousa MMA; Vieira MA; Andrade CEMDC
Int J Gynecol Cancer; 2018 Oct; 28(8):1520-1528. PubMed ID: 30036229
[TBL] [Abstract] [Full Text] [Related]
15. Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease.
Ter Veer E; van Rijssen LB; Besselink MG; Mali RMA; Berlin JD; Boeck S; Bonnetain F; Chau I; Conroy T; Van Cutsem E; Deplanque G; Friess H; Glimelius B; Goldstein D; Herrmann R; Labianca R; Van Laethem JL; Macarulla T; van der Meer JHM; Neoptolemos JP; Okusaka T; O'Reilly EM; Pelzer U; Philip PA; van der Poel MJ; Reni M; Scheithauer W; Siveke JT; Verslype C; Busch OR; Wilmink JW; van Oijen MGH; van Laarhoven HWM
Lancet Oncol; 2018 Mar; 19(3):e151-e160. PubMed ID: 29508762
[TBL] [Abstract] [Full Text] [Related]
16. Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2.
Oza AM; Tinker AV; Oaknin A; Shapira-Frommer R; McNeish IA; Swisher EM; Ray-Coquard I; Bell-McGuinn K; Coleman RL; O'Malley DM; Leary A; Chen LM; Provencher D; Ma L; Brenton JD; Konecny GE; Castro CM; Giordano H; Maloney L; Goble S; Lin KK; Sun J; Raponi M; Rolfe L; Kristeleit RS
Gynecol Oncol; 2017 Nov; 147(2):267-275. PubMed ID: 28882436
[TBL] [Abstract] [Full Text] [Related]
17. Systematic differences between ultrasound and pathological evaluation of thyroid nodules: a method comparison study.
Chew CR; Lam T; Chan STF; Chin-Lenn L
ANZ J Surg; 2018 May; 88(5):464-467. PubMed ID: 28608502
[TBL] [Abstract] [Full Text] [Related]
18. Utility of I-124 PET/CT in identifying radioiodine avid lesions in differentiated thyroid cancer: a systematic review and meta-analysis.
Santhanam P; Taieb D; Solnes L; Marashdeh W; Ladenson PW
Clin Endocrinol (Oxf); 2017 May; 86(5):645-651. PubMed ID: 28160320
[TBL] [Abstract] [Full Text] [Related]
19. Multi-functional nanoparticles as theranostic agents for the treatment & imaging of pancreatic cancer.
Jaidev LR; Chellappan DR; Bhavsar DV; Ranganathan R; Sivanantham B; Subramanian A; Sharma U; Jagannathan NR; Krishnan UM; Sethuraman S
Acta Biomater; 2017 Feb; 49():422-433. PubMed ID: 27890622
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic factors and staging systems in parathyroid cancer: a multicenter cohort study.
Villar-del-Moral J; Jiménez-García A; Salvador-Egea P; Martos-Martínez JM; Nuño-Vázquez-Garza JM; Serradilla-Martín M; Gómez-Palacios A; Moreno-Llorente P; Ortega-Serrano J; de la Quintana-Basarrate A
Surgery; 2014 Nov; 156(5):1132-44. PubMed ID: 25444314
[TBL] [Abstract] [Full Text] [Related]
[Next]
